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INTRODUCTION
Interleukin-1 (ILl) is known to be an important media-
tor of the immune system, produced primarily by mono-
nuclear phagocytes in response to injury and infection.
ILIa and ILl13 are two forms of the same class of
interleukin-1, eliciting various biological activities, de-
pending on the type of cell with which they interact. A
closely related protein, IL1RA, acts as an antagonist by
binding to ILl's receptor. We describe crystallographic
and modeling studies of the structures and functional
parts of these interleukins.
STRUCTURAL DETAILS OF IL1P AND IL1a
These two forms of ILl are initially synthesized as 31-kD
precursors and are cleaved by proteases to release
mature biologically active 17-kD proteins. With an
amino acid homology between them of - 25%, they are
structurally similar and appear to carry out the same
function by binding to a common receptor. For a
detailed review of ILl, see references 1-3. To identify
the structural requirements for receptor activation, we
used protein crystallographic techniques to obtain the
three-dimensional structure of ILl13. The detailed struc-
ture and a possible receptor binding epitope has been
reported (4). Crystallographic and nuclear magnetic
resonance (NMR) structures of these (5-8) and a few
other site-directed mutants of ILl 13 (9) have been solved
and the coordinates submitted to the Protein Data
Bank.
THREE-DIMENSIONAL STRUCTURE OF IL1P
The molecule resembles a conical barrel with a shallow
open face on one end and a closed face on the other. The
molecule contains 12 antiparallel13-strands, where six of
these (131, 134, 135, 138, 139, and 1312) constitute an antipar-
allel 13 barrel. The overall structure of the molecule
consists of three similar fragments (F1, F2, F3), each
containing two pairs of 13 strands. Three pairs of 13
strands (one pair from each of the fragments) form the
six stranded barrel; the other three pairs cover one end
of the barrel, referred to as the "closed end." The amino
and carboxy termini are close to each other at the "open
end" of the barrel. The molecule has internal pseudo
threefold symmetry, with each subunit (F1, F2, F3) hav-
ing a 13I3I3L13 motif. There are five 13-hairpins in this
molecule, two of them in the open end and three at the
closed end. The polypeptide a-carbon backbone of
ILl13, viewed perpendicular to the barrel axis, is shown
in Fig. 1. 24 hydrophobic side chains line the inner
surface of the barrel and both the ends of the barrel have
concentrations of exposed polar residues.
THREE-DIMENSIONAL STRUCTURE OF IL1a
The crystallographic structure of ILla has been deter-
mined (8); its general fold is very similar to that of ILl13,
having the same central 13-barrel along with the adjoin-
ing loops. The major difference in the two molecules is
an NHz-terminal extension of 14 residues beyond the
NHz-terminus of ILl-13. As explained in reference 8,
there are some additional features in ILIa: a short
13-strand near the NHz-terminus (residues 6-10), an-
other short strand (residues 97-99) and about two turns
of 310 helix (residues 101-105). The strands are 131 =
14-23,132 = 24-33, 133 = 34-40, 134 = 48-58, 135 = 59-68,
136 = 69-80, 137 ::: 81-91, 138 ::z: 105-113, 139 = 114-121,
1310 :IE 122-132, 1311 = 133-140, 1312 = 146-153. The
pseudo threefold symmetry exhibited by ILl13 is also
present in ILIa, having 81 common atoms within a root
mean square distance of 1.54 A.
IL1-RECEPTOA ANTAGONIST
The pleiotropic activity of the same ILl molecule with
respect to different cells has to be regulated by the
system or otherwise would possibly lead to a uncon-
trolled and undesirable effects. Recent reports show
that there exists a naturally occurring protein which could
act as an interleukin-1 receptor antagonist (IL1RA),
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regulating ILl activity (10-12). ILlRA binds to the same
receptor with an affinity equal to that of ILla or ILl~
but does not induce ILl-like biological activity, con-
firming that it is a protein antagonist of ILL It is a 17-Kd
polypeptide whose primary structure shares 26% amino
acid homology to ILl~ and 19% homology to ILla.
Conserved amino acids in ILlRA have a 41% homology
to ILl~ and 30% to ILla. With the available structural
information on ILl, a tentative model of ILlRA has
been deduced and a comparison of the structures of
ILl~, ILla and ILlRA reveals significant functional
aspects of these proteins.
MODELING STRATEGY
The available amino acid sequences of ILl, purified
from various sources, were aligned by using a mutation
data matrix, also by considering the features essential
for ILl's common fold as obtained from the three-
TABLE 1 The amino acId sequences of IL1-~, IL1... and IL1RA _re aligned by using MACAW and slso by considering the available three-
dimensional structural details.
ILl-~ bl b2 b3 b4
Il1-~ no. 3 ----------12 17---21 25---29 40-------------52
~-Rat VP I RQLHCRLRD EQQK CLVLS DP-C ELKAL HLNGQN 1 SQQ VVFSMS FVQGETS
~-Mouse VPIRQLHYRLRD EQQK SLVLS DP-Y ELKAL HLNGQN I NQQ VIFSMSFVQGEPS
~-Rabbit AVRSLHCRLQD AQQK SLVLS GT-Y ELKAL HLNAENLNQQ VVFSMS FVQGEES
~-Sheep AAVQSVKCKLQD REQK SLVLD S P-C VLKAL HLLSQEMSRE VVFCMS FVQGEER
~-Bovine APVQS I KCKLQD REQK SLVLA S P-C VLKAL HLLSQEMNRQ VVFCMS FVQGEER
~-Human APVRSLNCTLRD SQQK SLVMS GP-Y ELKAL HLQGQDMEQQ VVFSMS FVQGEES
RA-Human RPSGRKSSKMQAFRIWD VNQK TFYLR N--N QLVAG YLQGPNVNLE EKIDVVPI EPH--
a-Human SAPFSFLSNVKYNFMRIIKYEFILND ALNQ SIIRA ND-Q YLTAA ALH--NLDEA VKFDMGAYK S S KD
a-Bovine SAHYSFQSNVKYNFMRVI HQECI LMD ALNQ SI I RD MSGP YLTAT TLN--NLDDA VKFDMVAYVSEED
a-Rabbit SVPYTFQRNMRYKYLRIIKQEFILMD ALNQ SLVRD TSDQ YLRAA PLQ--NLGDA VKFDMGVYMT S ED
a-Mouse SAPYTYQSDLRYKLMKLVRQKFVMND SLNQ TIYQD VDKH YLSTT WLN--DLQQE VKFDMYAYS SGGD
a-Rat SAPHSFQNNLRYKLIRIVKQEFIMND SLNQ NIYVD MDRI HLKAA SLN--DLQLE VKFDMYAYS SGGD
ILl pro no. 119---------- 128 133---137 141---145 156-------------168
b5 b6 b7 b8
Il1-~ no. 55------62 66 --------74 77-------85 100-----106
~-Rat ND KI PVALGL KGK NLYLSCVMK DG TPTLQLESV D-PKQYPKKKMEKRF VFNKIEV
~-Mouse ND KIPVALGL KGK NLYLSCVMK DG TPTLQLESV D-PKQYPKKKMEKRF VFNKIEV
~-Rabbit ND KIPVALGL RGK NLYLSCVMK DD KPTLQLESV D-PNRYPKKKMEKRF VFNKIEI
~-Sheep DN KI PVALGI RDK NLYLSCVKK GD TPTLQLEEV D-PKVYPKRNMEKRF VFYKTEI
~-Bovine DN KI PVALGI KDK NLYLSCVKK GD TPTLQLEEV D-PKVYPKRNMEKRF VFYKTEI
~-Human ND KIPVALGL KEK NLYLSCVLK DD KPTLQLESV D-PKNYPKKKMEKRF VFNKIEI
RA-Human --ALFLGI HGG KMCLSCVKS GD ETRLQLEAV NITDLSENRKQDKRF AFIRSDS
a-Human DA KITVILRI SKT QLYVTAQDE E- QPVLLKEMP P-EI PKTITGSETNL LFFWETH
a-Bovine -S QLPVTLRI SKT QLFVSAQNE E- EPVLLKEMP P-- -TPKI IKDETNL LFFWEKH
a-Rabbit -S I LPVTLRI SQT PLFVSAQNE E- EPVLLKEMP P--TPRI ITDSESDI LFFWETQ
a-Mouse DS KYPVTLKI SDS QLFVSAQGE E- QPVLLKELP P- -TPKLITGS ETDL IFFWKS 1
a-Rat DS KYPVTLKV SNT QLFVSAQGE E- KPVLLKEI P p. - TPKL I TGS ETDL IFFWEKI
ILl pro no. 171------178 182-------190 193 -------201 216-----222
b9 blO bll bl2
III-~ no. 109----114 120----125 130-----135 142------------152
~-Rat KT KVEFES AQFPN WYISTS QAEH RPVFLG NSNG--R D I VDFTMEPVS S 152
~-Mouse KS KVEFES AEFPN WYISTS QAEH KPVFLG NNSG--Q D I IDFTMESVSS 152
~-Rabbit KD KLEFES AQFPN WYISTS QTEY MPVFLG NNSG--Q DL IDFSMEFVSS 152
~-Sheep KN TVEFES VLYPN WYISTS QIEE KPVFLG RFRG-GQ D I TDFRMETL S P 153
~-Bovine KN TVEFES VLYPN WYISTS QIEE RPVFLG HFRA-GQ D I TDFRMETLSP 153
~-Human NN KLEFES AQFPN WYISTS QAEN MPVFLG GTKG-GQ D I TDFTMQFVS S 153
RA-Human GP TTSFES AACPG WFLCTA MEAD QPVSLT NMPDEGV MVTKFY FQEDE 152
a-Human GT KNYFTS VAHPN LFIATK Q--D YWVCLA GGP---P S I TDFQ I LENQA 159
a-Bovine GS MDYFKS VAHPK LFIATK Q--E KLVHMA SGP---P S I TDFQ 1 LEK - - 155
a-Rabbit GN KNYFKS AANPQ LFIATK P--E HLVHMA RGL---P SMTDFQ 1 S-- -- 150
a-Mouse NS KNYFTS AAYPE LFIATK E--Q S RVHLA RGL---P SMTDFQ 1 S-- -- 155
a-Rat NS KNYFTS AAFPE LLIATK E--Q SQVHLA RGL---P SMI DFQ 1 S---- 156
ILl pro no. 225----230 236----241 246-----251 258------------268 269
The l3-strands (131 to 1312) of ILl 13 are also marked.
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FIGURE I The a-carbon backbone atoms of IL-ll3, viewed perpendic-
ular to the axis of the barrel.
dimensional structures of ILl-J3 and ILl-a (Table 1).
While doing so, it was kept in mind that the matching
patterns of residue conservation should be higher in the
J3-barrel core, and the fold not only maintains the
structural integrity of any protein but also enables the
placement of the functionally important residues in
correct juxtaposition. Because ILl and ILlRA bind to
the same receptor, their binding surface should be
similar but their opposite functional characteristics sug-
gests that the functional aspect of ILl should be absent
in IL1RA. Because their functions are quite different,
the alignment was carried out manually wherever the
residues concerned with the proposed epitope ap-
peared. Initial alignment was done by comparing the
three-dimensional structures of human ILl-J3 and ILl-a
and the alignment was extended to the rest of the
sequences. In the case IL1-RA the sequence similarity
seems to be closer to ILlJ3 than ILla.
Model building was performed by using graphics
programs FRODO on Evans and Sutherland PS390
graphics system and QUANTA (Polygen Co.) on a
Silicon Graphics 4D/70 IRIS workstation with the
procedure as follows. Based on the main chain of IL1-J3,
a model of ILlRA was obtained using the sequence
alignment (Table 1). The side chains of the ILl J3 were
replaced for the appropriate residue of ILlRA to
generate the required primary sequence, leaving the
backbone unaltered. Conformational angles of the new
side chains were retained as a start and a visual scanning
of torsion angles about each bond of a residue was done
to look for any van der Waals contacts between atoms on
either side of the bond. The optimal alignment of the
primary sequences, however, required deletions at 23,
between 51 and 56, and an insertion of lIe between
FIGURE 2 Superposition of the a-carbon backbones of ILla, ILl 13 and ILlRA.
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positions 86 and 87, Glu between 139 and 140 (ILlJ3
numbering). Insertions and deletions with respect to
ILia have been done, wherever necessary. All the
deletions and insertions are apparently on the loop
regions which are present on the surface of the molecule
and not within the barrel staves. The next step involved
several cycles of sterochemical regularization and en-
ergy minimization by using the program QUANTA and
obtained model was then subjected to molecular dynam-
ics coupled with energy minimization and regularization
procedure using the program XPLOR.
The crystallographic and deduced models possess the
same ILl-fold (secondary structure) and maintain very
similar backbone hydrogen bonding pattern and also
have similar nonbonding energies. Superposition of the
a-carbon backbones of ILla, ILlJ3, and ILlRA are
shown in Fig. 2, which reveals that their spatial structure
are close to each other in all regions of the protein
except in the regions of deletion and insertion. We
proposed in our earlier paper that the receptor binding
epitope of ILl should be large, formed by various
segments of the molecule. Similar regions such as the
surface polar loops exist in the ILlRA structure and so it
could be conceived that these loops are required for the
binding. The observable major difference is that the
binding loop, having the immunostimulatory sequence
50-56 (EESNDKI), is not present in ILlRA and there
are subtle changes observed in the open end of the
barrel. These small structural differences might playa
major role in the functional aspects of ILL The coordi-
nates of the model have been deposited in the Protein
Data Bank and are also available from the author.
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